Ketoprofen was third in all the years evaluated, followed by tramadol (2012–2015) or sliding scale insulin (that is, an antidiabetic approach consisting of the correction of hyperglycemia through the frequent administration of short-acting insulin, dosed according to a patient’s blood glucose level; 2016–2018). This evidence concerns the gene INS and Hyperglycemia.